Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Alterity Therapeutics Limited”

4 pharma patents match "Alterity Therapeutics Limited" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "Alterity Therapeutics Limited" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “Alterity Therapeutics Limited” · 30,257 patents in full index Clear search

  1. US 11603364

    Acyl hydrazone derivative compounds for treating disease

    Alterity Therapeutics Limited · Granted Mar 14, 2023 · Expires Mar 9, 2043

    granted

  2. US 11357770

    Method of treating immunoglobulin light chain amyloidosis

    Alterity Therapeutics Limited · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted

  3. US 11155547

    Compounds for and methods of treating diseases

    Alterity Therapeutics Limited · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted

  4. US 10941143

    Imidazo [1,5-a]pyridine compounds and their use

    Alterity Therapeutics Limited · Granted Mar 9, 2021 · Expires Mar 4, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.